Erratum to “p53 expression in cytology samples may represent a marker of early-stage cancer”

IF 2.6 3区医学 Q3 ONCOLOGY

Cancer Cytopathology Pub Date : 2023-10-21 DOI:10.1002/cncy.22773

引用次数: 0

Abstract

This erratum corrects the following:

Policardo F, Tralongo P, Arciuolo D, et al. p53 expression in cytology samples may represent a marker of early-stage cancer. Cancer Cytopathol. 2023;131(6):392-401. doi:10.1002/cncy.22694

Please note that the surname of one of the authors, Lina Cardisciani, was misspelled as “Cardasciani.”

The authors regret this error.

查看原文本刊更多论文

“细胞学样本中p53表达可能代表早期癌症的标志物”的勘误表。

本勘误更正如下：Policardo F, Tralongo P, Arciuolo D, et al. 细胞学样本中 p53 的表达可能是早期癌症的标志物。Cancer Cytopathol.2023;131（6）：392-401.doi:10.1002/cncy.22694请注意，作者之一 Lina Cardisciani 的姓氏拼错为 "Cardasciani"。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer Cytopathology 医学-病理学

CiteScore

7.00

自引率

17.60%

发文量

130

审稿时长

1 months

期刊介绍： Cancer Cytopathology provides a unique forum for interaction and dissemination of original research and educational information relevant to the practice of cytopathology and its related oncologic disciplines. The journal strives to have a positive effect on cancer prevention, early detection, diagnosis, and cure by the publication of high-quality content. The mission of Cancer Cytopathology is to present and inform readers of new applications, technological advances, cutting-edge research, novel applications of molecular techniques, and relevant review articles related to cytopathology.